Skip to content

Lifecore Biomedical, Inc. LFCR Change in Other Assets

Change in Other Assets at other companies

Baxter International logo
Baxter InternationalBAX
-$2M-108%
ADMA Biologics logo
ADMA BiologicsADMA
$1.6M-38.3%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$1.8M-89.8%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$19K-26.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$653K-289%
Labcorp Holdings logo
Labcorp HoldingsLH
-$4M+91.1%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s change in other assets?
Lifecore Biomedical, Inc. (LFCR) reported change in other assets of -$209K in Q1 2026.
How has Lifecore Biomedical, Inc.'s change in other assets changed year-over-year?
Lifecore Biomedical, Inc.'s change in other assets increased by 87.1% year-over-year, from -$1.61M to -$209K.
What is the long-term trend for Lifecore Biomedical, Inc.'s change in other assets?
Over 2 years (2023 to 2025), Lifecore Biomedical, Inc.'s change in other assets has grown at a -58.1% compound annual growth rate (CAGR), from -$2.16M to -$378K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.